Pesquisa | Biblioteca Virtual em Saúde

1.

The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison.

Sherman, David G; Albers, Gregory W; Bladin, Christopher; Fieschi, Cesare; Gabbai, Alberto A; Kase, Carlos S; O'Riordan, William; Pineo, Graham F.

Lancet ; 369(9570): 1347-1355, 2007 Apr 21.

Artigo em Inglês | MEDLINE | ID: mdl-17448820

2.

Stroke prevention in atrial fibrillation: pharmacological rate versus rhythm control.

Sherman, David G.

Stroke ; 38(2 Suppl): 615-7, 2007 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-17261701

3.

Safety and tolerability of arundic acid in acute ischemic stroke.

Pettigrew, L Creed; Kasner, Scott E; Albers, Gregory W; Gorman, Mark; Grotta, James C; Sherman, David G; Funakoshi, Yosuke; Ishibashi, Hideyasu.

J Neurol Sci ; 251(1-2): 50-6, 2006 Dec 21.

Artigo em Inglês | MEDLINE | ID: mdl-17095018

4.

Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study.

Sherman, David G; Kim, Soo G; Boop, Bradley S; Corley, Scott D; Dimarco, John P; Hart, Robert G; Haywood, L Julian; Hoyte, Keith; Kaufman, Elizabeth S; Kim, Michael H; Nasco, Elaine; Waldo, Albert L.

Arch Intern Med ; 165(10): 1185-91, 2005 May 23.

Artigo em Inglês | MEDLINE | ID: mdl-15911734

5.

Prevention of venous thromboembolism, recurrent stroke, and other vascular events after acute ischemic stroke: the role of low-molecular-weight heparin and antiplatelet therapy.

Sherman, David G.

J Stroke Cerebrovasc Dis ; 15(6): 250-9, 2006.

Artigo em Inglês | MEDLINE | ID: mdl-17904084

6.

Lessons from the Stroke Prevention in Atrial Fibrillation trials.

Hart, Robert G; Halperin, Jonathan L; Pearce, Lesly A; Anderson, David C; Kronmal, Richard A; McBride, Ruth; Nasco, Elaine; Sherman, David G; Talbert, Robert L; Marler, John R.

Ann Intern Med ; 138(10): 831-8, 2003 May 20.

Artigo em Inglês | MEDLINE | ID: mdl-12755555

7.

Enoxaparin versus unfractionated heparin in the prevention of venous thromboembolism after acute ischemic stroke: rationale, design, and methods of an open-label, randomized, parallel-group multicenter trial.

Sherman, David G; Soltes, Sandor; Samuel, Rita; Chibedi-Deroche, Daniela.

J Stroke Cerebrovasc Dis ; 14(3): 95-100, 2005.

Artigo em Inglês | MEDLINE | ID: mdl-17904007

8.

Ancrod.

Sherman, David G.

Curr Med Res Opin ; 18 Suppl 2: s48-52, 2002.

Artigo em Inglês | MEDLINE | ID: mdl-12365829

9.

Transient ischemic attack--proposal for a new definition.

Albers, Gregory W; Caplan, Louis R; Easton, J Donald; Fayad, Pierre B; Mohr, J P; Saver, Jeffrey L; Sherman, David G.

N Engl J Med ; 347(21): 1713-6, 2002 Nov 21.

Artigo em Inglês | MEDLINE | ID: mdl-12444191

10.

Functional status in rate- versus rhythm-control strategies for atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy.

Chung, Mina K; Shemanski, Lynn; Sherman, David G; Greene, H Leon; Hogan, David B; Kellen, Joyce C; Kim, Soo G; Martin, Lisa Warsinger; Rosenberg, Yves; Wyse, D George.

J Am Coll Cardiol ; 46(10): 1891-9, 2005 Nov 15.

Artigo em Inglês | MEDLINE | ID: mdl-16286177

11.

Antithrombotic and hypofibrinogenetic therapy in acute ischemic stroke: what is the next step?

Sherman, David G.

Cerebrovasc Dis ; 17 Suppl 1: 138-43, 2004.

Artigo em Inglês | MEDLINE | ID: mdl-14694291

12.

Reconsideration of TIA diagnostic criteria.

Sherman, David G.

Neurology ; 62(8 Suppl 6): S20-1, 2004 Apr 27.

Artigo em Inglês | MEDLINE | ID: mdl-15111652

Biblioteca Virtual em Saúde

Saúde Pública Brasil

Sua seleção (0)

Formato de exportação:

Exportar:

The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison.

Stroke prevention in atrial fibrillation: pharmacological rate versus rhythm control.

Safety and tolerability of arundic acid in acute ischemic stroke.

Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study.

Prevention of venous thromboembolism, recurrent stroke, and other vascular events after acute ischemic stroke: the role of low-molecular-weight heparin and antiplatelet therapy.

Lessons from the Stroke Prevention in Atrial Fibrillation trials.

Enoxaparin versus unfractionated heparin in the prevention of venous thromboembolism after acute ischemic stroke: rationale, design, and methods of an open-label, randomized, parallel-group multicenter trial.

Ancrod.

Transient ischemic attack--proposal for a new definition.

Functional status in rate- versus rhythm-control strategies for atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy.

Antithrombotic and hypofibrinogenetic therapy in acute ischemic stroke: what is the next step?

Reconsideration of TIA diagnostic criteria.